Transformed Lymphoma

• CLINICAL_TRIALS research · 2026-04-23
  Clinical Trial Update: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma [Phase 1]

  Phase 1 clinical trial evaluating mosunetuzumab consolidation after autologous stem cell transplantation in relapsed/refractory aggressive B…

• CLINICAL_TRIALS research · 2026-03-10
  Clinical Trial Update: Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma [Phase 1, Phase 2]

  Acalabrutinib is being studied as maintenance therapy in a Phase 1/2 trial for large B-cell lymphomas, including diffuse large B-cell lympho…

• CLINICAL_TRIALS trial_result · 2026-03-02
  Clinical Trial Update: Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

  Clinical trial update reporting on neurocognitive effects and patient-reported outcomes for axicabtagene ciloleucel in diffuse large B-cell …

• CLINICAL_TRIALS trial_result · 2026-02-11
  Clinical Trial Update: Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma [Phase 1]

  A Phase 1 exploratory study evaluated CD19-targeted CAR T cells (BZ019) in relapsed/refractory B-cell lymphomas, including diffuse large B-c…

• CLINICAL_TRIALS research · 2025-01-13
  Clinical Trial Update: Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 clinical trial update on locally manufactured CAR T-cell products for multiple B-cell malignancies, including B-cell lymphoma and B-…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-01-26
  Clinical Trial Update: DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma [Phase 2]

  Phase 2 protocol update for DLCL002 in high-risk aggressive B-cell lymphoma patients.

• CLINICAL_TRIALS trial_result · 2021-03-15
  Clinical Trial Update: Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL [Phase 1, Phase 2]

  Phase 1/2 trial evaluating tislelizumab plus lenalidomide in refractory/relapsed elderly patients with various aggressive B-cell lymphomas, …

• CLINICAL_TRIALS trial_result · 2014-09-05
  Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…